Literature DB >> 27292773

Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults.

Yuhei Hamaguchi1, Toshimi Kaido2, Shinya Okumura1, Atsushi Kobayashi1, Ahmed Hammad3, Yumiko Tamai4, Nobuya Inagaki5, Shinji Uemoto1.   

Abstract

OBJECTIVES: Low skeletal muscle, referred to as sarcopenia, has been shown to be an independent predictor of lower overall survival in various kinds of diseases. Several studies have evaluated the low skeletal muscle mass using computed tomography (CT) imaging. However, the cutoff values based on CT imaging remain undetermined in Asian populations.
METHODS: Preoperative plain CT imaging at the third lumbar vertebrae level was used to measure the psoas muscle mass index (PMI, cm(2)/m(2)) in 541 adult donors for living donor liver transplantation (LDLT). We analyzed PMI distribution according to sex or donor age, and determined the sex-specific cutoff values of PMI to define low skeletal muscle mass.
RESULTS: PMI in men was significantly higher than observed in women (8.85 ± 1.61 cm(2)/m(2) versus 5.77 ± 1.21 cm(2)/m(2); P < 0.001). PMI was significantly lower in individuals ≥50 y than in younger donors in both men and women (P < 0.001 and P < 0.001, respectively). On the basis of the younger donor data, we determined the sex-specific cutoff values for the low skeletal muscle mass were 6.36 cm(2)/m(2) for men and 3.92 cm(2)/m(2) for women (mean - 2 SD).
CONCLUSION: Data from healthy young Asian adults were used to establish new criteria for low skeletal muscle mass that would be applicable for defining sarcopenia in Asian populations.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Cutoff value; Healthy young population; Living donor liver transplantation; Psoas muscle mass index; Sarcopenia

Mesh:

Year:  2016        PMID: 27292773     DOI: 10.1016/j.nut.2016.04.003

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  109 in total

1.  The psoas muscle index as a predictor of long-term survival after cardiac surgery for hemodialysis-dependent patients.

Authors:  Soki Kurumisawa; Koji Kawahito
Journal:  J Artif Organs       Date:  2019-05-27       Impact factor: 1.731

2.  Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.

Authors:  B A Derstine; S A Holcombe; R L Goulson; B E Ross; N C Wang; J A Sullivan; G L Su; S C Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Ohshio; Keigo Okamoto; Ryosuke Kaku; Kazuki Hayashi; Takuya Shiratori; Makoto Yoden
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-04-10

4.  Impact of Preoperative Skeletal Muscle Quality Measurement on Long-Term Survival After Curative Gastrectomy for Locally Advanced Gastric Cancer.

Authors:  Yuhei Waki; Tomoyuki Irino; Rie Makuuchi; Akifumi Notsu; Satoshi Kamiya; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

5.  Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.

Authors:  Noriko Ishii; Yoshinori Iwata; Hiroki Nishikawa; Hirayuki Enomoto; Nobuhiro Aizawa; Akio Ishii; Yuho Miyamoto; Yukihisa Yuri; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Yoshiyuki Sakai; Naoto Ikeda; Tomoyuki Takashima; Ryo Takata; Hiroko Iijima; Shuhei Nishiguchi
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

6.  Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.

Authors:  Kuniaki Katsui; Takeshi Ogata; Kenta Watanabe; Kotaro Yoshio; Masahiro Kuroda; Masaomi Yamane; Takao Hiraki; Katsuyuki Kiura; Shinichi Toyooka; Susumu Kanazawa
Journal:  Int J Clin Oncol       Date:  2021-04-20       Impact factor: 3.402

7.  A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer.

Authors:  Rikiya Hasegawa; Kosuke Okuwaki; Mitsuhiro Kida; Hiroshi Yamauchi; Yusuke Kawaguchi; Takaaki Matsumoto; Toru Kaneko; Eiji Miyata; Kazuho Uehara; Tomohisa Iwai; Masafumi Watanabe; Takahiro Kurosu; Hiroshi Imaizumi; Takashi Ohno; Wasaburo Koizumi
Journal:  Int J Clin Oncol       Date:  2019-07-15       Impact factor: 3.402

8.  Psoas muscle size as a magnetic resonance imaging biomarker of progression of pancreatitis.

Authors:  Andre E Modesto; Charlotte E Stuart; Jaelim Cho; Juyeon Ko; Ruma G Singh; Maxim S Petrov
Journal:  Eur Radiol       Date:  2020-02-10       Impact factor: 5.315

9.  Clinical Impact of Preoperative Sarcopenia on the Postoperative Outcomes After Pancreas Transplantation.

Authors:  Yasunari Fukuda; Tadafumi Asaoka; Hidetoshi Eguchi; Kazuki Sasaki; Yoshifumi Iwagami; Daisaku Yamada; Takehiro Noda; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Toshinori Ito; Yutaka Takeda; Masahiro Tanemura; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

10.  What is the most useful body composition parameter for predicting toxicities of preoperative chemotherapy for gastric cancer?

Authors:  Tadayoshi Hashimoto; Yukinori Kurokawa; Tsuyoshi Takahashi; Takuro Saito; Kotaro Yamashita; Koji Tanaka; Tomoki Makino; Makoto Yamasaki; Masaaki Motoori; Yutaka Kimura; Kiyokazu Nakajima; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2019-11-11       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.